Loading data
GEVNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 38.07 bn USD | 34.94 bn USD | 33.24 bn USD | 29.65 bn USD | 33.01 bn USD |
| Cost of revenue | 30.53 bn USD | 28.85 bn USD | 28.42 bn USD | 26.2 bn USD | 28.06 bn USD |
| Gross profit | 7.54 bn USD | 6.09 bn USD | 4.82 bn USD | 3.46 bn USD | 4.95 bn USD |
| Research and development expense | 1.2 bn USD | 982 m USD | 896 m USD | 979 m USD | 1.01 bn USD |
| Selling, general and administrative expense | 4.95 bn USD | 4.63 bn USD | 4.85 bn USD | 5.36 bn USD | 4.82 bn USD |
| Operating profit | 1.39 bn USD | 471 m USD | -923 m USD | -2.88 bn USD | -884 m USD |
| Profit before tax | 2.83 bn USD | 2.5 bn USD | -130 m USD | -2.47 bn USD | -864 m USD |
| Income tax expense | -2.05 bn USD | 939 m USD | 344 m USD | 248 m USD | -140 m USD |
| Net income (reported basis) | 4.88 bn USD | 1.56 bn USD | -438 m USD | -2.74 bn USD | -633 m USD |
| Basic earnings per share | 17.92 USD/share | 5.65 USD/share | -1.6 USD/share | -10 USD/share | — |
| Diluted earnings per share | 17.69 USD/share | 5.58 USD/share | -1.6 USD/share | -10 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.